WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech Innovation
Posted: Jan 12th, 2026In: Press ReleasesWBB Securities President Dr. Steve Brozak moderated a panel at Biotech Showcase 2026 focused on ARPA-H and the role of federal investment in advancing biotech and healthcare innovation. The discussion featured senior ARPA-H leaders and[...]
Read More about WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech InnovationWBB Securities Initiates Coverage of Turn Therapeutics (Nasdaq: TTRX)
Posted: Jan 12th, 2026In: Press ReleasesWBB Securities, LLC has initiated research coverage of Turn Therapeutics, Inc. (NasdaqCM: TTRX), a clinical-stage biotechnology company focused on developing therapies for inflammatory skin and infectious diseases.
Read More about WBB Securities Initiates Coverage of Turn Therapeutics (Nasdaq: TTRX)OYE Therapeutics Raises $5.475 Million Series A to Advance High-Concentration Caffeine Therapy
Posted: Dec 16th, 2025In: Press ReleasesOYE Therapeutics Raises $5.475 Million Series A to Advance High-Concentration Caffeine Therapy. WBB Securities LLC acted as the placement agent for the Series A financing.
Read More about OYE Therapeutics Raises $5.475 Million Series A to Advance High-Concentration Caffeine TherapyWBB Securities acted as the sole placement agent for a $9 million Series A funding round for FELIQS
Posted: Jul 1st, 2025In: Press ReleasesWBB Securities today announced it had acted as the sole placement agent for a $9 million Series A funding round for FELIQS, a biotechnology company developing first-in-class small molecule therapeutics for rare pediatric retinal[...]
Read More about WBB Securities acted as the sole placement agent for a $9 million Series A funding round for FELIQS
WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.
Posted: May 27th, 2025In: Press ReleasesWBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.
Read More about WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.Dr. Steve Brozak, President of WBB Securities, will moderate a panel at the Biotech Showcase Conference on Wednesday, January 15, 2025, titled “The Need for Novel Responses to Disease Threats in a Fast-Changing World.”
Posted: Jan 14th, 2025In: Press ReleasesThe Need for Novel Responses to Disease Threats in a Fast-Changing World.
Read More about Dr. Steve Brozak, President of WBB Securities, will moderate a panel at the Biotech Showcase Conference on Wednesday, January 15, 2025, titled “The Need for Novel Responses to Disease Threats in a Fast-Changing World.”On Thursday, October 19, 2023, the WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations titled “A Tale of Two Pandemics: 1889 & 2019, Insights for Pandemic Preparedness.”
Posted: Oct 19th, 2023In: Press ReleasesOn Thursday, October 19, 2023, the WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations titled “A Tale of Two Pandemics: 1889 & 2019, Insights for Pandemic[...]
Read More about On Thursday, October 19, 2023, the WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations titled “A Tale of Two Pandemics: 1889 & 2019, Insights for Pandemic Preparedness.”WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations: “A Tale of Two Pandemics: Lessons from the 1889 & 2019 Pandemics”
Posted: Oct 13th, 2023In: Press ReleasesFor Immediate Release October 13, 2023 Cranford, NJ– On Thursday, October 19th, WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations, examining how responses to prior influenza[...]
Read More about WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations: “A Tale of Two Pandemics: Lessons from the 1889 & 2019 Pandemics”WBB SECURITIES PRESIDENT STEVE BROZAK WILL MODERATE A PANEL AT THE BIOFUTURE CONFERENCE ON FRIDAY, OCTOBER 6, 2023
Posted: Oct 5th, 2023In: Press ReleasesOn Friday, October 6, Steve Brozak, Managing Partner and President of WBB Securities will moderate a panel discussion titled: “Infectious Disease: From Neglect to Respect Made Possible by New Technologies” at the BioFuture forum in[...]
Read More about WBB SECURITIES PRESIDENT STEVE BROZAK WILL MODERATE A PANEL AT THE BIOFUTURE CONFERENCE ON FRIDAY, OCTOBER 6, 2023
WBB Securities and WBB Research Institute Sponsored Demy-Colton’s Virtual Salon, A Discussion of the Current Status in Solid Tumor Treatments and Future Innovations.
Posted: Sep 20th, 2023In: Press Releases“Exploring Solid Tumor Treatment At Its Core: a Conversation with Prominent KOLS and Its Future” A presentation and discussion that featured up-to-date information about the role of iRGD peptides...
Read More about WBB Securities and WBB Research Institute Sponsored Demy-Colton’s Virtual Salon, A Discussion of the Current Status in Solid Tumor Treatments and Future Innovations.